Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumour-modifying therapy].

Nina Aass1, Kristin Bjordal, Kjell Magne Tveit

  • 1Regionalt kompetansesenter for lindrende, behandling, Helse Sør Rikshospitalet-Radiumhospitalet HF, Montebello 0310, Oslo. nina.aass@radiumhospitalet.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|March 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caregiver satisfaction with early integrated palliative care in oncology: secondary outcomes from the PALLiON cluster-RCT.

Frontiers in oncology·2026
Same author

Linking Inflammation to Reduced Food Intake in Advanced Cancer: A Prospective Observational Study.

Current oncology (Toronto, Ont.)·2026
Same author

Cognitive function in long-term survivors after treatment for brain metastases compared with normative samples.

Neuro-oncology practice·2026
Same author

Reply to 'Comment on "Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis"'.

International journal of cancer·2025
Same author

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.

The Lancet. Oncology·2025
Same author

Unmet supportive care needs among head and neck cancer survivors beyond 5 years after diagnosis: a multinational cohort study.

The Lancet regional health. Europe·2025

Palliative cancer treatments like radiotherapy and chemotherapy can relieve symptoms and potentially prolong life in advanced cancer patients. Minimizing treatment toxicity is crucial, with shortened radiotherapy and regular systemic therapy evaluation being key strategies.

Area of Science:

  • Oncology
  • Palliative Care
  • Cancer Therapeutics

Context:

  • Focuses on patients with advanced malignant disease and limited life expectancy.
  • Highlights the current reliance on empirical data and clinical experience over evidence-based medicine for treatment decisions.
  • Emphasizes the critical need to minimize acute treatment-related toxicity in this patient population.

Purpose:

  • To explore the role of radiotherapy and systemic cancer treatments (hormones, chemotherapy) in managing symptoms and potentially prolonging life.
  • To discuss strategies for optimizing treatment efficacy and minimizing toxicity, including shortened radiotherapy regimens and careful systemic therapy monitoring.
  • To review the use of bisphosphonates for hypercalcemia and prevention of skeletal events in patients with bone metastases.

Summary:

Related Experiment Videos

  • Radiotherapy and systemic treatments can provide symptom relief and prevention in advanced cancer, sometimes extending life.
  • Minimizing treatment toxicity is paramount; shortened radiotherapy and regular systemic therapy evaluation are recommended.
  • Bisphosphonates are standard for hypercalcemia and can reduce skeletal events in patients with bone metastases and a prognosis of at least six months.

Impact:

  • Informs clinical practice regarding the management of advanced cancer patients with short life expectancies.
  • Suggests approaches to improve quality of life and potentially outcomes through optimized and less toxic cancer therapies.
  • Underscores the importance of individualized treatment evaluation and the role of bisphosphonates in managing bone metastases.